合成路线1
该中间体在本合成路线中的序号:
(IV) Reaction of 2-(2-chlorobenzoyl)acetonitrile (I) with 4-(4-isobutylphenyl)butyraldehyde (II) and sulfur in DMF/NEt3 gives 2-amino-3-(2-chlorobenzoyl)-5-[2-(4-isobutylphenyl)ethyl]thiophene (III), which is acylated with 2-chloropropionyl chloride (IV) in chloroform to give 2-(2-chloropropionamido)-3-(2-chlorobenzoyl)-5-[2-(4-isobutylphenyl) ethyl]thiophene (V). Compound (V) is treated with sodium iodide in THF followed by liquid ammonia to give 2-(2-aminopropionamido)-3-(2-chlorobenzoyl)-5-[2-(4-isobutylphenyl) ethyl]thiophene (VI), which is cyclized in isopropanol and acetic acid to give 5-(2-chlorophenyl)-5-[2-(4-isobutylphenyl)ethyl]-3-methyl-2,3-dihydro-1H-thieno[2,3-e]-1,4-diazepin-2-one (VII). Compound (VII) gives 5-(2-chlorophenyl)-7-[2-(4-isobutylphenyl)ethyl]-3-methyl-2,3-dihydro-1H-thieno[2,3-e]-1,4-diazepin-2-thione (VIII) upon treatment with Lawesson's reagent. Finally, (VIII) is cyclized with hydrazine hydrate and ethyl orthoformiate.
【1】
Tahara, T.; Moriwaki, M.; Abe, M.; Yuasa, S. (Welfide Corporation); PAF-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof. EP 0268242; JP 1989156982; US 4820703 .
|
【2】
Castaner, J.; Prous, J.; Mealy, N.; Y-24180. Drugs Fut 1993, 18, 11, 1016.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12923 |
3-(2-Chlorophenyl)-3-oxopropanenitrile
|
40018-25-5 |
C9H6ClNO |
详情 | 详情
|
(II) |
12924 |
4-(4-Isobutylphenyl)butanal
|
|
C14H20O |
详情 |
详情
|
(III) |
12925 |
[2-Amino-5-(4-isobutylphenethyl)-3-thienyl](2-chlorophenyl)methanone
|
|
C23H24ClNOS |
详情 |
详情
|
(IV) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(V) |
12927 |
2-Chloro-N-[3-(2-chlorobenzoyl)-5-(4-isobutylphenethyl)-2-thienyl]propanamide
|
|
C26H27Cl2NO2S |
详情 |
详情
|
(VI) |
12928 |
2-Amino-N-[3-(2-chlorobenzoyl)-5-(4-isobutylphenethyl)-2-thienyl]propanamide
|
|
C26H29ClN2O2S |
详情 |
详情
|
(VII) |
12929 |
5-(2-Chlorophenyl)-7-(4-isobutylphenethyl)-3-methyl-1,3-dihydro-2H-thieno[2,3-e][1,4]diazepin-2-one
|
|
C26H27ClN2OS |
详情 |
详情
|
(VIII) |
12930 |
5-(2-Chlorophenyl)-7-(4-isobutylphenethyl)-3-methyl-1,3-dihydro-2H-thieno[2,3-e][1,4]diazepine-2-thione
|
|
C26H27ClN2S2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) Acylation of 1-acetyl-1,2,3,4-tetrahydroquinoline (I) with 2-chloropropionyl chloride (II) by means of AlCl3 provides the quinoline derivative (III), which is deacetylated by treatment with HCl to give 1,2,3,4-tetrahydro-6-(2-chloropropionyl)quinoline (IV). Condensation of compound (IV) with O-ethyl hydrazinethioformate (V) in refluxing acetonitrile yields the thiadiazinone (VI), which is then N-acylated at the quinoline ring with 3,4-dimethoxybenzoyl chloride (VII) by means of Et3N in methylene chloride to give the racemate EMD-53998 [rac-(VIII)]. Optical resolution of EMD-53998 can be performed by two different ways: a) enantioseparation via chromatography with Chiralpak AD in 100% EtOH as eluent and b) acylation of EMD-53998 with (S)-camphanoyl chloride (IX) by means of Et3N in methylene chloride followed by treatment with morpholine in the same solvent to afford a mixture of ()-EMD-53998 (EMD-57439) and the camphanoyl amide (X), which are separated by chromatography. Finally, the (+)-enantiomer, EMD-57033, is isolated by further treatment of amide (X) with morpholine in methylene chloride.
【1】
Strube, J.; Jupke, A.; Schmidt-Traub, H.; Schulte, M.; Epping, A.; Devant, R.; Design, optimization, and operation of SMB chromatography in the production of enantiomerically pure pharmaceuticals. Chirality 1999, 11, 440.
|
【2】
Castaner, J.; Doggrell, S.A.; Brown, L.; EMD-57033. Drugs Fut 2002, 27, 1, 14.
|
【3】
Jonas, R.; Piulats, J.; Lues, I.; Klockow, M. (Merck Patent GmbH); Thiadiazinones. AU 8816646; DE 3719031; DE 3744149; EP 0294647; JP 1988310886; US 4916128 .
|
【4】
Klockow, M.; Lues, I.; Jonas, R.; Preparation of the enantiomers of the novel Ca-sensitizer EMD 53 998. Bioorg Med Chem Lett 1992, 2, 6, 589.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51475 |
1-[3,4-dihydro-1(2H)-quinolinyl]-1-ethanone
|
|
C11H13NO |
详情 |
详情
|
(II) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(III) |
51476 |
1-(1-acetyl-1,2,3,4-tetrahydro-6-quinolinyl)-2-chloro-1-propanone
|
|
C14H16ClNO2 |
详情 |
详情
|
(IV) |
51477 |
2-chloro-1-(1,2,3,4-tetrahydro-6-quinolinyl)-1-propanone
|
|
C12H14ClNO |
详情 |
详情
|
(V) |
51478 |
O-ethyl 1-hydrazinecarbothioate
|
|
C3H8N2OS |
详情 |
详情
|
(VI) |
51479 |
6-methyl-5-(1,2,3,4-tetrahydro-6-quinolinyl)-3,6-dihydro-2H-1,3,4-thiadiazin-2-one
|
|
C13H15N3OS |
详情 |
详情
|
(VII) |
13488 |
(2S)-3-Butyn-2-ol; (S)-(-)-3-Butyn-2-ol
|
2914-69-4 |
C4H6O |
详情 | 详情
|
(VIII) |
51480 |
5-[1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolinyl]-6-methyl-3,6-dihydro-2H-1,3,4-thiadiazin-2-one
|
|
C22H23N3O4S |
详情 |
详情
|
(IX) |
16583 |
(1S,4R)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carbonyl chloride; (-)-Camphanic chloride
|
39637-74-6 |
C10H13ClO3 |
详情 | 详情
|
(X) |
51481 |
5-[1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydro-6-quinolinyl]-6-methyl-3-[[(4R)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]hept-1-yl]carbonyl]-3,6-dihydro-2H-1,3,4-thiadiazin-2-one
|
|
C32H35N3O7S |
详情 |
详情
|
(XI) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) Friedel-Crafts acylation of acetanilide (I) with 2-chloropropionyl chloride (II) in the presence of AlCl3 provided ketone (III). The chlorine atom of (III) was then displaced with dimethylamine to afford amino ketone (IV), which was reduced to alcohol (V) using NaBH4 in MeOH. Treatment of alcohol (V) with carbonyl diimidazole furnished the imidazolyl derivative (VI). The acetamido group of (VI) was then hydrolyzed with 3N HCl to give aniline (VII). This compound was converted to isothiocyanate (VIII) by treatment with thiophosgene and NaOH. Alternatively, aniline (VII) was treated with carbon disulfide and NaOH and then with iodomethane to give the bis(methylthio)methyleneamino derivative (IX). The condensation of either (VIII) or (IX) with 2-aminothiophenol (X) produced the target benzothiazole (XI) as a mixture of isomers. Then, separation of the diastereoisomers by column chromatography, followed by resolution by chiral HPLC, furnished the title (S,S)-isomer.
【1】
Venet, M.; Van Wauwe, J.; Mabire, D.; Sanz, G.; Poignet, H.; Wouters, J.; Synthesis of R116010, a retinoic acid (RA) metabolism inhibitor with antitumoral effects. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PC-60.
|
【2】
Venet, M.G.; Mabire, D.J.-P.; Lacrampe, J.F.A.; Sanz, G.C. (Janssen Pharmaceutica NV); N-[4-(heteroarylmethyl)phenyl]-heteroarylamines. EP 0907650; JP 2000503670; US 6124330; WO 9749704 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(Va) |
46351 |
N-[4-[(1R,2S)-2-(dimethylamino)-1-hydroxypropyl]phenyl]acetamide
|
|
C13H20N2O2 |
详情 |
详情
|
(Vb) |
46352 |
N-[4-[(1S,2S)-2-(dimethylamino)-1-hydroxypropyl]phenyl]acetamide
|
|
C13H20N2O2 |
详情 |
详情
|
(VIa) |
46353 |
N-[4-[(1R,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl]acetamide
|
|
C16H22N4O |
详情 |
详情
|
(VIb) |
46354 |
N-[4-[(1S,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl]acetamide
|
|
C16H22N4O |
详情 |
详情
|
(VIIa) |
46355 |
N-[(1S,2R)-2-(4-aminophenyl)-2-(1H-imidazol-1-yl)-1-methylethyl]-N,N-dimethylamine; 4-[(1R,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]aniline
|
|
C14H20N4 |
详情 |
详情
|
(VIIb) |
46356 |
N-[(1S,2S)-2-(4-aminophenyl)-2-(1H-imidazol-1-yl)-1-methylethyl]-N,N-dimethylamine; 4-[(1S,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]aniline
|
|
C14H20N4 |
详情 |
详情
|
(VIIIa) |
46357 |
(1R,2S)-1-(1H-imidazol-1-yl)-1-(4-isothiocyanatophenyl)-N,N-dimethyl-2-propanamine; N-[(1S,2R)-2-(1H-imidazol-1-yl)-2-(4-isothiocyanatophenyl)-1-methylethyl]-N,N-dimethylamine
|
|
C15H18N4S |
详情 |
详情
|
(VIIIb) |
46358 |
N-[(1S,2S)-2-(1H-imidazol-1-yl)-2-(4-isothiocyanatophenyl)-1-methylethyl]-N,N-dimethylamine; (1S,2S)-1-(1H-imidazol-1-yl)-1-(4-isothiocyanatophenyl)-N,N-dimethyl-2-propanamine
|
|
C15H18N4S |
详情 |
详情
|
(IXa) |
46359 |
1-[(1R,2S)-1-(4-[[bis(methylsulfanyl)methylene]amino]phenyl)-2-(dimethylamino)propyl]-1H-imidazole
|
|
C17H24N4S2 |
详情 |
详情
|
(IXb) |
46360 |
1-[(1S,2S)-1-(4-[[bis(methylsulfanyl)methylene]amino]phenyl)-2-(dimethylamino)propyl]-1H-imidazole
|
|
C17H24N4S2 |
详情 |
详情
|
(XIa) |
46361 |
N-[4-[(1R,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl]-1,3-benzothiazol-2-amine; N-(1,3-benzothiazol-2-yl)-N-[4-[(1R,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl]amine
|
|
C21H23N5S |
详情 |
详情
|
(XIb) |
46362 |
N-[4-[(1S,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl]-1,3-benzothiazol-2-amine; N-(1,3-benzothiazol-2-yl)-N-[4-[(1S,2S)-2-(dimethylamino)-1-(1H-imidazol-1-yl)propyl]phenyl]amine
|
|
C21H23N5S |
详情 |
详情
|
(I) |
10194 |
N-Phenylacetamide; Acetanilide
|
103-84-4 |
C8H9NO |
详情 | 详情
|
(II) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(III) |
46349 |
N-[4-(2-chloropropanoyl)phenyl]acetamide
|
|
C11H12ClNO2 |
详情 |
详情
|
(IV) |
46350 |
N-[4-[2-(dimethylamino)propanoyl]phenyl]acetamide
|
|
C13H18N2O2 |
详情 |
详情
|
(X) |
25182 |
2-aminobenzenethiol
|
137-07-5 |
C6H7NS |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(XIII) In an alternative procedure, 2-aminothiophenol (X) was condensed with phenyl isothiocyanate (XII) to produce N-phenyl-2-aminobenzothiazole (XIII). Subsequent Friedel-Crafts acylation of (XIII) with acid chloride (II) gave chloro ketone (XIV), which was converted to amino ketone (XV) upon treatment with dimethylamine. After ketone (XV) reduction with NaBH4, the resulting amino alcohol (XVI) was treated with carbonyl diimidazole, and the mixture of isomers was chromatographically separated as above.
【1】
Venet, M.; Van Wauwe, J.; Mabire, D.; Sanz, G.; Poignet, H.; Wouters, J.; Synthesis of R116010, a retinoic acid (RA) metabolism inhibitor with antitumoral effects. 16th Int Symp Med Chem (Sept 18 2000, Bologna) 2000, Abst PC-60.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVIa) |
46367 |
(1R,2S)-1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-(dimethylamino)-1-propanol
|
|
C18H21N3OS |
详情 |
详情
|
(XVIb) |
46368 |
(1S,2S)-1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-(dimethylamino)-1-propanol
|
|
C18H21N3OS |
详情 |
详情
|
(X) |
25182 |
2-aminobenzenethiol
|
137-07-5 |
C6H7NS |
详情 | 详情
|
(XI) |
46363 |
benzenesulfenyl cyanide
|
|
C7H5NS |
详情 |
详情
|
(XII) |
46364 |
N-(1,3-benzothiazol-2-yl)-N-phenylamine; N-phenyl-1,3-benzothiazol-2-amine
|
|
C13H10N2S |
详情 |
详情
|
(XIII) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(XIV) |
46365 |
1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-chloro-1-propanone
|
|
C16H13ClN2OS |
详情 |
详情
|
(XV) |
46366 |
1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-(dimethylamino)-1-propanone
|
|
C18H19N3OS |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(III) The cyclization of 1,3-diphenylthiourea (I) with Br2 and HBr in water gives N-(benzothiazol-2-yl)-N-phenylamine (II), which is condensed with 2-chloropropionyl chloride (III) by means of AlCl3 in dichloromethane to yield the propiophenone (IV). The reaction of (IV) with dimethylamine in isopropanol affords the racemic alpha-(dimethylamino) propiophenone (V), which is optically resolved by means of (+)(D)-di-p-toluoyltartaric acid providing the (S)-enantiomer (VI) with a 80% ee. The reduction of (VI) with NaBH4 and NaOH in isopropanol gives the (S,S)-enantiomer (VII) with a 85% ee. Finally, this compound is condensed with CDI and imidazole to afford the target compound that is purified by crystallization in ethyl acetate up to a 99% ee.
【1】
Aelterman, W.; et al.; Conversion of the laboratory synthetic route of the N-aryl-2-benzothiazolamine R116010 to a manufacturing method. Org Process Res Dev 2001, 5, 5, 467.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56953 |
1,3-Diphenyl-2-thiourea; 1,3-Diphenylthiourea; N,N'-Diphenylthiourea; S-Diphenylthiocarbamide; sym-Diphenylthiourea; Thiocarbanilide
|
102-08-9 |
C13H12N2S |
详情 | 详情
|
(II) |
46364 |
N-(1,3-benzothiazol-2-yl)-N-phenylamine; N-phenyl-1,3-benzothiazol-2-amine
|
|
C13H10N2S |
详情 |
详情
|
(III) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(IV) |
46365 |
1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-chloro-1-propanone
|
|
C16H13ClN2OS |
详情 |
详情
|
(V) |
46366 |
1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-(dimethylamino)-1-propanone
|
|
C18H19N3OS |
详情 |
详情
|
(VI) |
56954 |
(2S)-1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-(dimethylamino)-1-propanone
|
|
C18H19N3OS |
详情 |
详情
|
(VII) |
46368 |
(1S,2S)-1-[4-(1,3-benzothiazol-2-ylamino)phenyl]-2-(dimethylamino)-1-propanol
|
|
C18H21N3OS |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) Lorcaserin hydrochloride can be prepared by several different procedures. 4-Chlorophenethylamine (I) is acylated with 2-chloropropionyl chloride (II) in the presence of pyridine in CH2Cl2 to give the chloropropionamide (III), which is cyclized to the benzazepinone (IV) upon heating with AlCl3. Subsequent reduction of (IV) with either BH3 or LiAlH4 in Et2O affords the racemic lorcaserin (V) (1-3). In a related method, chloropropionamide (III) is reduced with borane in THF to yield the chloro amine (VIa), which is then cyclized to benzazepine (V) in the presence of AlCl3 (3). Alternatively, condensation of 4-chlorophenethyl bromide (VII) with 1-amino-2-propanol (VIII) provides the aminoalcohol (IX), which is converted to either the chloro amine (VIa) or the analogous bromo amine (VIb) by treatment with SOCl2 or SOBr2, respectively (3). Optical resolution of tetrahydrobenzazepine (V) either employing chiral HPLC or by crystallization with D-tartaric acid furnishes the target (R)-enantiomer (X) (1-3). This is finally converted to the title hydrochloride salt by treatment with HCl in different solvent systems (4). In a further procedure, after protection of 4-chlorophenethylamine (I) as the corresponding trifluoroacetamide (XI) by means of trifluoroacetic anhydride and pyridine in CH2Cl2, iodination with bis(pyridine)iodonium tetrafluoroborate in the presence of trifluoromethanesulfonic acid furnishes (XII). Subsequent alkylation of trifluoroacetamide (XII) with allyl bromide under phase transfer conditions leads to the iodo olefin (XIII), which undergoes intramolecular Heck cyclization in the presence of Pd(OAc)2 and PPh3 to furnish the methylene benzazepine (XIV). After reduction of (XIV) to the methyl analogue (XV) by catalytic hydrogenation over Pd/C, the N-trifluoroacetyl group is hydrolyzed with NaOH in aqueous MeOH to give 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (V) (5). Scheme 1.
【1】
Smith, B., Smith, J., Schultz, J., Gilson, C. III (Arena Pharmaceuticals, Inc.). Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases. EP 1633720, JP 2007516941, WO 2005003096. |
【2】
Smith, B.M., Smtih, J.M., Tsai, J.H. et al. Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity. Bioorg Med Chem Lett 2005, 15(5): 1467-70. |
【3】
Burbaum, B.W., Gilson, C.A. III, Aytes, S. et al. (Arena Pharmaceuticals, Inc.). Processes for preparing 3-benzazepines. EP 1636191, JP 2007521269, WO 2005019179. |
【4】
Agarwal, R.K., Betts, W.L. III, Henshilwood, J.A., Kiang, Y.-H., Post, N. (Arena Pharmaceuticals, Inc.). Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride. WO 2006069363. |
【5】
Smith, B., Smith, J. (Arena Pharmaceuticals, Inc.). 5HT2C receptor modulators. EP 1557409, JP 2005527579, JP 2006143751, US 2003225057, US 6953787, WO 2003086306. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VIb) |
65408 |
4-Chloro-N-(2-bromopropyl)benzeneethanamine |
|
C11H15BrClN |
详情 | 详情
|
(Via) |
65407 |
4-Chloro-N-(2-chloropropyl)benzeneethanamine |
897926-35-1 |
C11H15Cl2N |
详情 | 详情
|
(I) |
29459 |
4-chlorophenethylamine; 2-(4-chlorophenyl)-1-ethanamine
|
156-41-2 |
C8H10ClN |
详情 | 详情
|
(II) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(III) |
65404 |
2-chloro-n-(2-(4-chlorophenyl)ethyl)propanamide; 1-((2-(4-chlorophenyl)ethyl)amino)-1-oxo-2-chloropropane |
34164-14-2 |
C11H13Cl2NO |
详情 | 详情
|
(IV) |
65405 |
8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one |
824430-77-5 |
C11H12ClNO |
详情 | 详情
|
(V) |
65406 |
Lorcaserin A; 8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine |
616201-80-0 |
C11H14ClN |
详情 | 详情
|
(VII) |
65409 |
4-Chlorophenethyl bromide; 1-(2-Bromoethyl)-4-chlorobenzene |
6529-53-9 |
C8H8BrCl |
详情 | 详情
|
(VIII) |
41397 |
1-amino-2-propanol
|
78-96-6 |
C3H9NO |
详情 | 详情
|
(IX) |
65410 |
1-[[2-(4-Chlorophenyl)ethyl]amino]-2-hydroxypropane |
847063-13-2 |
C11H16ClNO |
详情 | 详情
|
(X) |
65411 |
(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine; Lorcaserin |
616202-92-7 |
C11H14ClN |
详情 | 详情
|
(XI) |
65412 |
|
|
C10H9ClF3NO |
详情 | 详情
|
(XII) |
65413 |
|
|
C10H8ClF3INO |
详情 | 详情
|
(XIII) |
65414 |
|
|
C13H12ClF3INO |
详情 | 详情
|
(XIV) |
65415 |
|
|
C13H11ClF3NO |
详情 | 详情
|
(XV) |
65416 |
|
|
C13H13ClF3NO |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(V)
【1】
Duan YB.Zhang GH,“Y.et al.2004.Facile synthesis of articaine hydrochloride.中国药物化学杂志.14: 109--111 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
66119 |
methacrylonitrile |
126-98-7 |
C4H5N |
详情 | 详情
|
(II) |
18838 |
methyl 2-sulfanylacetate
|
2365-48-2 |
C3H6O2S |
详情 | 详情
|
(III) |
66120 |
methyl 3-amino-4-methylthiophene-2-carboxylate |
|
C7H9NO2S |
详情 | 详情
|
(IV) |
66121 |
methyl 3-(2-chloropropanamido)-4-methylthiophene-2-carboxylate |
|
C10H12ClNO3S |
详情 | 详情
|
(V) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(V)
【1】
Kadushkin AV, Trofimkin YI, Granik VG. 2002. Method for the manufacture of methyl 4-methyl-3-[2-(1-propylanuno) propionylanuno] thiophene-2-carboxylate hydrochloride which does not require vacucun distillation purirication RU 2184730 |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
12926 |
2-Chloropropanoyl chloride; 2-Chloropropionyl chloride
|
7623-09-8 |
C3H4Cl2O |
详情 | 详情
|
(III) |
66120 |
methyl 3-amino-4-methylthiophene-2-carboxylate |
|
C7H9NO2S |
详情 | 详情
|
(VI) |
23923 |
1-propanamine
|
107-10-8 |
C3H9N |
详情 | 详情
|